Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by amorakon Aug 03, 2011 12:24am
346 Views
Post# 18897607

RE: RE: RE: RE: RE: RE: RE: RE: RE: RE: RE: Neptun

RE: RE: RE: RE: RE: RE: RE: RE: RE: RE: RE: NeptunCuriosity got the better of me! I had to take a look at NT.
.
Viking, you've got to slow down on that krill oil! NTB is NOT in the same space that RVX is in, not with regard to it's market or its science! NTB isn't even in the same league with RVX. I've been making my living in the stock market for many years. I never touch a stock that depends on a potential environmental issue or on a natural pharmaceutical or nutraceutical product!
.
The customers for such products are fickle, the products can thus be fads. But the big issue for me is the FACT that most people, by far, are not proactive with their own health and that will always limit markets for products in that space. People are mostly reactive with respect to their health. In other words, the health for most people must deteriorate to the point of medical intervention being required before they'll take action. That's where prescription drugs come into play. Since krill oil is already on the market and if it was magic then we all would know about it today, its use would be universal. 
.
The fact is, krill oil is marginally effective and that's good but hardly of blockbuster status. Moreover, the markets for krill oil and other marginal treatments are sensitive to new fads, new natural discoveries, and even more so to real scientific breakthroughs.
.
NBT is a nice a little deal in my mind but I can't touch anything like this that already has a market cap of a quarter billion, has an upside that can increase only incrementally (at best) and has no blockbuster potential.
.
RVX is altogether different. If the upcoming ASSURE trial is successful then RVX will be a blockbuster. We won't need to wait for Phase 3 to get a ten bagger, maybe even a twenty bagger. I think most people on this forum don't need me to further describe RVX and I'm not going to bother. It's all in the history here and well-described on the RVX website.
.
If you don't want any risk coupled with the usual small payoff associated with low risk then go for NTB. If you want a huge payoff and can stand the risk, then RVX is your play. You might well consider that RVX has never had any kind of a setback with respect to its science. It's had financing issues and management issues but never a problem with the science.
.
There's more to say about NTB but I already know enough to prove to me that it's no RVX. I have no place for it in my world. I gotta say that Neptune is touting some pretty forward-looking stuff in order to keep investors interested. If RVX investors want to see the difference between RVX's closed-mouthed management style and how another management toots its own horn, go read the NTB stuff.
.
Bullboard Posts